HIV/AIDS, Hepatitis, Infectious Disease News

Statin Use in Hospitalized DM Patients With COVID-19 Associated with Lower Mortality

By

November 24, 2020

Study authors assess the association between statin therapy and in-hospital mortality in patients with COVID-19 and concomitant diabetes mellitus.

COVID19

LT-RAMP Provides Accurate and Rapid COVID-19 Detection: A Real World Study

By

Zahra Masoud

November 24, 2020

Researchers compared a novel reverse transcription loop-mediated isothermal amplification method to the gold standard, reverse transcription polymerase chain reaction, and assessed the accuracy in detecting SARS-CoV-2.

Sepsis

Beta-Blockers for Heart Rate Control in Sepsis-Associated Atrial Fibrillation

By

Brandon May

November 24, 2020

Treatment with beta-blockers vs amiodarone, calcium channel blockers, or digoxin was associated with improved heart control at 1, but not 6 hours in patients with sepsis and atrial fibrillation.

The researchers examined teenage pregnancy rates among a total of 27,000 women in both PEPFAR-funded and nonfunded countries and found no difference in rates between the two.

COVID19

COVID-19 Does Not Predispose Women to Early Pregnancy Loss

By

Bradley van Paridon

November 23, 2020

Investigators assessed the effect of linked HIV and SARS-CoV-2 testing on reduction in HIV incidence and indirect total health care costs.

COVID19

Effect of PEEP in COVID-19-Related ARDS Similar to Classical ARDS

By

Virginia A. Schad, PharmD, RPh

November 23, 2020

The effects of positive end expiratory pressure in COVID-19-related acute respiratory distress syndrome (ARDS) are similar to those reported in classical ARDS.

COVID19

Assessing the Effect of Antimalarial Drug Shortages in Rheumatic Disease During the COVID-19 Pandemic

By

Chen Fang, PharmD, RPh

November 23, 2020

The COVID-19 Global Rheumatology Alliance Patient Experience Survey was used to assess the effect of antimalarial drug shortages during the COVID-19 pandemic.

Uncategorized

CREDIBLE-CR: Cefiderocol Effective for Serious Carbapenem-Resistant Gram-Negative Infections

By

Bradley van Paridon

November 20, 2020

Study authors assessed the efficacy and safety of cefiderocol vs best available therapy in adults with serious carbapenem-resistant Gram-negative infections.